• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

The Bethesda System for Reporting Thyroid Cytopathology and to Assess Risk of Malignancy in Bastar Region

    Dr Nitya Thakur, Dr Deepika Dhruw, Dr B P Singh, Dr Kasturi Mangrulkar

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1398-1407

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Thyroid lesions are of great importance because most are amenable to Medical or Surgical management. The Medical diagnosis of Thyroid lesions is crucial as Malignancy necessitates Surgery while follow-up is important just in case of Benign lesions. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was introduced in 2007 to standardize terminology utilized in reporting thyroid cytology.
Material and Methods: A retrospective observational study of already diagnosed cases of Thyroid in FNAC was performed in the Department of Pathology at Late BRKM Medical College, Bastar over a three years period from January 2017 to December 2019. The FNAC smears were reclassified according to the 6 diagnostic categories of TBSRTC.We could pursue follow up Histology for 160 cases. The diagnosis offered in FNAC was compared with that observed on Histopathological examination.
Results: On cytology out of 386 cases, 21(5.44%) categorized as Non-Diagnostic/ Unsatisfactory Samples, 338 (87.56%) cases as Benign Follicular Nodule, And 10 (2.59%) as Atypia of Undetermined Significance/Atypical Follicular Lesion of Undetermined Significance (AUS/AFLUS), 3 (0.78%) as Follicular Neoplasm/Suspected Follicular Neoplasm (FN/SFN), 4 (1.04%) as Suspicious For Malignancy, and 10 Cases (2.59%) as Malignant. Histopathological follow-up of 160 cases. The malignancy rate for the Non-Diagnostic category was 0%, Benign category was 1.44%, AUS/FLUS category was 33.33%, FN/SFN category was 50%. Suspicious for Malignancy category was 66.66%, malignant category was 100%.
Conclusion: The Bethesda system is the most suitable reporting system for cytopathology of Thyroid lesions. It minimizes the surgical procedure for benign lesions.
Keywords:
  • PDF (879 K)
  • XML
(2022). The Bethesda System for Reporting Thyroid Cytopathology and to Assess Risk of Malignancy in Bastar Region. European Journal of Molecular & Clinical Medicine, 9(1), 1398-1407.
Dr Nitya Thakur, Dr Deepika Dhruw, Dr B P Singh, Dr Kasturi Mangrulkar. "The Bethesda System for Reporting Thyroid Cytopathology and to Assess Risk of Malignancy in Bastar Region". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 1398-1407.
(2022). 'The Bethesda System for Reporting Thyroid Cytopathology and to Assess Risk of Malignancy in Bastar Region', European Journal of Molecular & Clinical Medicine, 9(1), pp. 1398-1407.
The Bethesda System for Reporting Thyroid Cytopathology and to Assess Risk of Malignancy in Bastar Region. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 1398-1407.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 78
  • PDF Download: 88
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus